PHAR - Pharming Group to attend the following Investor Conferences in June

PR Newswire

LEIDEN, The Netherlands , May 25, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management will attend the following investor conferences in the month of June:

• Jefferies Healthcare Conference, New York , U.S., June 7 - 9
  Pharming's CEO, Sijmen de Vries, will present on Thursday, June 8 at 10:30 EST / 16:30 CEST . A live webcast and replay of the presentation will be available in the "Upcoming Events" and "News" sections of Pharming's website.
• Stifel European Healthcare Summit, Bordeaux, France , June 28 - 30
• IEX Beleggers dag ( IEX Shareholder's day) , Bussum, the Netherlands , June 30
  Pharming's CEO, Sijmen de Vries, will present on Friday, June 30 at 11:30 CEST / 05:30 EST

Pharming's management will be available for one-to-one investor meetings during the Jefferies and Stifel conferences.

For more information about these conferences, or to schedule a one-to-one with Pharming's management team, please contact your Jefferies or Stifel representative, or send an email to Pharming's Investor Relations team to investor@pharming.com .

About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands , and has employees around the globe who serve patients in over 30 markets in North America , Europe , the Middle East , Africa , and Asia-Pacific .

For more information, visit www.pharming.com and find us on LinkedIn .

For further public information, contact:

Pharming Group, Leiden, The Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696

Heather Robertson , Investor Relations & Corporate Communications Manager
E: investor@pharming.com

FTI Consulting, London, UK
Victoria Foster Mitchell / Alex Shaw /Amy Byrne
T: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon Melens T: +31 6 53 81 64 27 E: pharming@lifespring.nl

SOURCE Pharming Group N.V.